Primary hyperparathyroidism with intrathyroidal location of parathyroid adenoma

Primary hyperparathyroidism is a common endocrine disease with high morbidity and mortality from all causes. The disease can be asymptomatic and for a long time remain undiagnosed, which leads to untimely surgical treatment, increases the risks of development and progression of severe disabling complications and worsens patients prognosis. In clinical practice there are certain difficulties in diagnosing this pathology. One of the urgent problems is the search for the source of parathyroid hormone hyperproduction, especially in case of atypical location of paraаdenoma. The most common atypical locations of altered parathyroid glands are thymus, retroor paraesophageal space, retropharyngeal space, mediastinum and thyroid gland. The frequency of intrathyroidal masses of parathyroid glands, in the thyroid parenchyma or under its capsule, ranges on average from 2 to 3%, but according to some authors can reach 18–22%. With such localization of paraadenomas there is a need for their differential diagnosis, first of all, with nodular formations of the thyroid gland. In addition, the absence of additional laboratory studies parathormone and calcium blood levels does not allow timely suspicion of the disease, and cytologic examination of the material obtained by fine-needle aspiration puncture biopsy does not allow reliable differentiation of the altered parathyroid gland. This article presents a clinical case of a patient with primary hyperparathyroidism with intrathyroidally located parathyroid adenoma, for a long time long identified as a “nodular goiter,” and provides a brief review of the methods that identify an intrathyroidally located parathyroma. Despite the abundance of diagnostic methods in visualization of intrathyroidal parathyroid glands, today the most appropriate seems to be expert ultrasound examination with assessment of the parathyroid hormone level in a washout after fine-needle aspiration, supplemented, if necessary, by scintigraphy and single-photon emission computed tomography combined with computed tomography or multispiral computed tomography.

1. Mokrysheva NG, Eremkina AK, Mirnaya SS, Krupinova JA, Voronkova IA, Kim IV et al. The clinical practice guidelines for primary hyperparathyroidism, short version. Problems of Endocrinology. 2021;67(4):94–124. (In Russ.) https://doi.org/10.14341/probl12801.

2. Clarke BL. Asymptomatic Primary Hyperparathyroidism. Front Horm Res. 2019:51:13–22. https://doi.org/10.1159/000491035.

3. Мaceri DR, Tai T. Parathyroid disease: a paradigm for disease management. Clin Surg. 2019;4:2385. Available at: https://www.clinicsinsurgery.com/openaccess/parathyroid-disease-a-paradigm-for-disease-management-3798.pdf.

4. Phitayakorn R, McHenry CR. Incidence and location of ectopic abnormal parathyroid glands. Am J Surп. 2006;191(3):418–423. https://doi.org/10.1016/j.amjsurg.2005.10.049.

5. Mariani G, Gulec SA, Rubello D, Boni G, Puccini M, Pelizzo MR et al. Preoperative localization and radioguided parathyroid surgery. J Nucl Med. 2003;44(9):1443–1458. Available at: https://pubmed.ncbi.nlm.nih.gov/12960191/.

6. Knepprath JK, McHenry CR. How often are intrathyroidal parathyroid glands a cause of primary hyperparathyroidism, and how should they be managed? Surgery. 2024;175(3):794–792. https://doi.org/10.1016/j.surg.2023.06.061.

7. Chandramohan J, Sigamani E, Abraham DT, Jacob PM, Cherian AJ, Chandramohan A et al. Intrathyroid parathyroid adenomas – uncommon tumours at unusual sites: a cross-sectional study. J Сlin Diag Res. 2020;14(8):12–17. https://doi.org/10.7860/JCDR/2020/23238.13922.

8. Satoh S, Mori Y, Tachibana T, Yokоi T, Yamashita H. Ten cases of intrathyroid parathyroid adenoma. J Jpn Soc Head Neck Surg. 2014;24(2):207–216. https://doi.org/10.5106/jjshns.24.207.

9. Roy M, Mazeh H, Chen H, Sippel RS. Incidence and localization of ectopic parathyroid adenomas in previously unexplored patients. World J Surg. 2013;37(1):102–106. https://doi.org/10.1007/s00268-012-1773-z.

10. Romanchishen AF, Matveeva ZA. Intrathyroid parathyroid adenomas. Vestnik Khirurgii Imeni I.I. Grekova. 2007:4(166):40–42. (In Russ.) Available at: https://cyberleninka.ru/article/n/intratireoidnye-paratireoadenomy.

11. Abdulkhabirova FM, Bondarenko EV, Fadeeva MI, Gadzira AN. Difficulties of clinical and cytological diagnosis of parathyroid carcinoma at the preoperative stage. Case report. Russian News of Clinical Cytology. 2023;27(2):30–34. (In Russ.) https://doi.org/10.24412/1562-4943-2023-2-0005.

12. Goodman A, Politz D, Lopez J, Norman J. Intrathyroid parathyroid adenoma: incidence and location--the case against thyroid lobectomy. Otolaryngol Head Neck Surg. 2011;144(6):867–871. https://doi.org/10.1177/0194599811400366.

13. Scheidt M, Hubbs D, Kabaker A, De Jong S. Completely intrathyroidal parathyroid adenoma in a patient with a previously failed cervical exploration. World J Endoc Surg. 2020;12(3):136–139. https://doi.org/10.5005/jp-journals-10002-1307.

14. Cho KJ, Park S-W, Won S, Kim JP, Park JJ. A case of hyperparathyroidism caused by intrathyroidal parathyroid adenoma. Int J Thyroidol. 2021;14(1):42–45. https://doi.org/10.11106/ijt.2021.14.1.42.

15. Mazeh H, Kouniavsky G, Schneider DF, Makris KI, Sippel R, Dackiw APB et al. Intrathyroidal parathyroid glands: small, but mighty (a napoleon phenomenon). Surgery. 2012;152(6):1193–1200. https://doi.org/10.1016/j.surg.2012.08.026.

16. Ovčariček PP, Giovanella L, Gasset IC, Hindié E, Huellner MW, Luster M et al. The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol. Imaging. 2021;48(9):2801–2822. https://doi.org/10.1007/s00259-021-05334-y.

17. Gowrishankar SV, Bidaye R, Das T, Majcher, Fish B, Casey R, Masterson L. Intrathyroidal parathyroid adenomas: Scoping review on clinical presentation, preoperative localization, and surgical treatment. Head Neck. 2023;45(3):706–720. https://doi.org/10.1002/hed.27287.

18. Abboud B, Sleilaty G, Ayoub S, Hachem K, Smayra T, Ghorra C, Abadjian G. Intrathyroid parathyroid adenoma in primary hyperparathyroidism: Can it be predicted preoperatively? World J Surg. 2007;31(4):817–823. https://doi.org/10.1007/s00268-006-0767-0.

19. Heller MT, Yip L, Tublin ME. Sonography of intrathyroid parathyroid adenomas: Are there distinctive features that allow for preoperative identification? Eur J Radiol. 2013;82(1):22–27. https://doi.org/10.1016/j.ejrad.2012.08.001.

20. Сentello R, Sesti F, Feola T, Sada V, Pandozzi C, Di Serafino M et al. The dark side of ultrasound imaging in parathyroid disease. J Clin Med. 2023;12(7):2487. https://doi.org/10.3390/jcm12072487.

21. Tsai K, Liang TZ, Grant EG, Swanson MS, Barnett B. Optimal imaging modality for diagnosis of parathyroid adenoma: Case report and review of the literature. J Clin Translat Endocrinol Case Rep. 2020;17:100065. https://doi.org/10.1016/j.jecr.2020.100065.

22. Heo I, Park S, Jung CW, Koh JS, Lee S-S, Seol H et al. Fine needle aspiration cytology of parathyroid lesions. Korean J Pathol. 2013;47(5):466–471. https://doi.org/10.4132/KoreanJPathol.2013.47.5.466.

23. Tseleni-Balafouta S, Gakiopoulou H, Kavantzas N, Agrogiannis G, Givalos N, Patsouris E. Parathyroid proliferations: a source of diagnostic pitfalls in FNA of thyroid. Cancer. 2007;111(2):130–136. https://doi.org/10.1002/cncr.22576.

24. Owens CL, Rekhtman N, Sokoll L, Ali SZ. Parathyroid hormone assay in fine-needle aspirate is useful in differentiating inadvertently sampled parathyroid tissue from thyroid lesions. Diagn Cytopathol. 2008;36(4):227–231. https://doi.org/10.1002/dc.20783.

25. Kim Е, Bondarenko Е, Eremkina А, Nikiforovich Р, Mokrysheva N. Silent intrathyroid parathyroid carcinoma. Endocrinol Diabetes Metab Case Rep. 2023;2023(2):23–27. https://doi.org/10.1530/EDM-23-0027.

26. Abati A, Skarulis MC, Shawker T, Solomon D. Ultrasound-guided fine-needle aspiration of parathyroid lesions: a morphological and immunocytochemical approach. Hum Pathol. 1995;26(3):338–343. https://doi.org/10.1016/0046-8177(95)90068-3.

27. Blind E, Schmidt-Gayk H, Sinn HP, O’Connor DT, Raue F. Chromogranin A as tumor marker in medullary thyroid carcinoma. Thyroid. 1992;2(1):5–10. https://doi.org/10.1089/thy.1992.2.5.

28. Triggiani V, Resta F, Giagulli VA, Iovino M, Licchelli B, De Pergola G et al. Parathyroid hormone determination in ultrasound-guided fine needle aspirates allows the differentiation between thyroid and parathyroid lesions: our experience and review of the literature. Endocr Metab Immunе Disord Drug Targets. 2013;13(4):351–358. https://doi.org/10.2174/1871530313666140108125645.

29. Carral F, Jiménez AI, Tomé M, Alvarez J, Diez A, Garcia C et al. Safety and diagnostic performance of parathyroid hormone assay in fine-needle aspirate in suspicious parathyroid adenomas. Endocrinol Diabetes Nutr (Engl Ed). 2021;68(7):481–488. https://doi.org/10.1016/j.endien.2020.07.004.

30. Ketha H, Lasho MA, Algeciras-Schimnich A. Analytical and clinical validation of parathyroid hormone (PTH) measurement in fine-needle aspiration biopsy (FNAB) washings. Clin Biochem. 2016;49(1):16–21. https://doi.org/10.1016/j.clinbiochem.2015.09.006.

31. Bancos I, Grant CS, Nadeem S, Stan MN, Reading CC, Sebo TJ et al. Risks and benefits of parathyroid fine-needle aspiration with parathyroid hormone washout. Endocr Pract. 2012;18(4):441–449. https://doi.org/10.4158/EP11148.OR.

32. Mazeh H, Kouniavsky G, Schneider DF, Makris KI, Sippel RS, Dackiw APB et al. Intrathyroidal parathyroid glands: small, but mighty (a napoleon phenomenon). Surgery. 2012;152(6):1193–1200. https://doi.org/10.1016/j.surg.2012.08.026.

33. Ye T, Huang X, Xia Y, Ma L, Wang L, Lai X et al. Usefulness of preoperative ultrasonographic localization for diagnosis of a rare disease: Intrathyroid parathyroid lesions. Medicine. 2018;97(23):1–5. https://doi.org/10.1097/MD.0000000000010999.

34. Zhao W, Lu R, Yin L, Wei B, Jin M, Zhang C et al. The value of preoperative and intraoperative ultrasound in the localization of intrathyroidal parathyroid adenomas. J Invest Surg. 2022;35(4):752–757. https://doi.org/10.1080/08941939.2021.1933273.

35. Merlino JI, Ko К, Minotti А, McHenry CR. The false negative technetium-99m-sestamibi scan in patients with primary hyperparathyroidism: correlation with clinical factors and operative findings. Am Surg. 2003;69(3):225–229. https://doi.org/10.1007/s12149-020-01520-4.

36. Dream S, Lindeman B, Chen H. Preventing blind thyroid lobectomy in patients with intrathyroidal hyperfunctioning parathyroid glands with radioguided enucleation. Int J Endocr Oncol. 2020;7(1):IJE28. https://doi.org/10.2217/ije-2019-0013.

37. Yabuta T, Tsushima Y, Masuoka H, Tomoda C, Fukushima M, Kihara M et al. Ultrasonographic features of intrathyroidal parathyroid adenoma causing primary hyperparathyroidism. Endocr J. 2011;58(11):989–994. https://doi.org/10.1507/endocrj.EJ11-0069.

38. Galvin L, Oldan JD, Bahl M, Eastwood JD, Sosa JA, Hoang JK. Parathyroid 4D CT and scintigraphy: what factors contribute to missed parathyroid lesions? Otolaryngol Head Neck Surg. 2016;154(5):847–853. https://doi.org/10.1177/0194599816630711.

39. Tian Y, Tanny ST, Einsiedel P, Lichtenstein M, Stella DL, Phal PM, Miller JA. Four-dimensional computed tomography: clinical impact for patients with primary hyperparathyroidism. Ann Surg Oncol. 2018;25(1):117–121. https://doi.org/10.1245/s10434-017-6115-9.

40. Traub-Weidinger T, Mayerhoefer ME, Koperek O, Mitterhauser M, Duan H, Karanikas G et al. 11C-methionine PET/CT imaging of 99mTc-MIBI-SPECT/ CT-negative patients with primary hyperparathyroidism and previous neck surgery. J Clin Endocrinol Metab. 2014:99(11):4199–4205. https://doi.org/10.1210/jc.2014-1267.

41. Seniaray N, Sharma H, Arbind A, Jaimini A, D’souza M, Saw S et al. 11C-Methionine positron emission tomography-computed tomography in localization of methoxyisobutyl isonitrile negative ectopic parathyroid adenoma. Indian J Nucl Med. 2016;31(1):49–51. https://doi.org/10.4103/0972-3919.172362.

42. Slashchuk KY, Degtyarev MV, Rumyantsev PO, Troshina EA, Melnichenko GA. Imaging methods of the parathyroid glands in primary hyperparathyroidism. Literature review. Endocrine Surgery. 2019;13(4):153–174. (In Russ.) https://doi.org/10.14341/serg12241.

43. Dream S, Lindeman B, Chen H. Preventing blind thyroid lobectomy in patients with intrathyroidal hyperfunctioning parathyroid glands with radioguided enucleation. Int J Endocr Oncol. 2020;7(1):IJE28. https://doi.org/10.2217/ije-2019-0013.

44. Shen W, Düren M, Morita E, Higgins C, Duh Q-Y, Siperstein AE, Clark OH. Reoperation for persistent or recurrent primary hyperparathyroidism. Arch Surg. 1996;131(8):861–867. https://doi.org/10.1001/archsurg.1996.01430200071013.

45. Kluijfhout WP, Venkatesh S, Beninato T, Vriens MR, Duh Q-Y, Wilson DM et al. Performance of magnetic resonance imaging in the evaluation of first-time and reoperative primary hyperparathyroidism. Surgery. 2016;160(3):747–754. https://doi.org/10.1016/j.surg.2016.05.003.

46. Lebastchi AH, Aruny JE, Donovan PI, Quinn CE, Callender GG, Carling T, Udelsman R. Real-time super selective venous sampling in remedial parathyroid surgery. J Am Coll Surg. 2015;220(6):994–1000. https://doi.org/10.1016/j.jamcollsurg.2015.01.004.